To Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended December 31, 2008

 

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT

 

For the transition period from ________ to ___________.

 

Commission file number: 1-16053

_________________

 


 

MEDIA SCIENCES INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

87-0475073

(State or other jurisdiction of incorporation or organization)

(IRS Employer Identification No.)

 

8 Allerman Road, Oakland, NJ 07436

(Address of principal executive offices) (Zip Code)

 

(201) 677-9311

(Registrant’s telephone number, including area code)

 

_________________

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (Check one):

 

Large accelerated filer o

Accelerated filer o

 

Non-accelerated filer o (Do not check if a smaller reporting company)

Smaller reporting company x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

As of February 11, 2009, we had 11,721,572 shares of common stock outstanding.

 


To Table of Contents

 

 

MEDIA SCIENCES INTERNATIONAL, INC.

AND SUBSIDIARIES

 

FORM 10-Q

FOR THE QUARTER ENDED DECEMBER 31, 2008

 

TABLE OF CONTENTS

 

 

PART I.  FINANCIAL INFORMATION

 

ITEM 1.

FINANCIAL STATEMENTS

3

 

 

 

 

Condensed Consolidated Balance Sheets as of December 31, 2008 (Unaudited) and June 30, 2008

3

 

 

 

 

Condensed Consolidated Statements of Operations for the Three Months and Six Months Ended December 31, 2008 and 2007 (Unaudited)

4

 

 

 

 

Condensed Consolidated Statement of Changes in Shareholders' Equity and Comprehensive Loss for the Six Months Ended December 31, 2008 (Unaudited)

5

 

 

 

 

Condensed Consolidated Statements of Cash Flows for the Six Months Ended December 31, 2008 and 2007 (Unaudited)

6

 

 

 

 

Notes to Condensed Consolidated Financial Statements

7

 

 

 

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

19

 

 

 

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

28

 

 

 

ITEM 4.

CONTROLS AND PROCEDURES

28

 

 

PART II.  OTHER INFORMATION

 

ITEM 1.

LEGAL PROCEEDINGS

29

 

 

 

ITEM 1A.

RISK FACTORS

29

 

 

 

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

29

 

 

 

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

29

 

 

 

ITEM 4.

SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

29

 

 

 

ITEM 5.

OTHER INFORMATION

30

 

 

 

ITEM 6.

EXHIBITS

30

 

 

 

SIGNATURES

 

31

 

 

2

 



To Table of Contents

 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1.   FINANCIAL STATEMENTS

 

MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

December 31,

 

 

 

2008

 

June 30,

ASSETS

(Unaudited)

 

2008

CURRENT ASSETS:

 

 

 

Cash and cash equivalents

$      719,475

 

$       236,571

Accounts receivable, net

3,023,675

 

3,082,516

Inventories

7,196,244

 

9,216,439

Taxes receivable

70,282

 

70,282

Deferred tax assets

772,288

 

772,288

Prepaid expenses and other current assets

304,883

 

285,241

Total Current Assets

12,086,847

 

13,663,337

 

 

 

 

PROPERTY AND EQUIPMENT, NET

3,127,431

 

2,472,570

 

 

 

 

OTHER ASSETS:

 

 

 

Goodwill and other intangible assets, net

3,584,231

 

3,584,231

Deferred tax assets

222,564

 

260,292

Other assets

130,427

 

124,359

Total Other Assets

3,937,222

 

3,968,882

 

 

 

 

TOTAL ASSETS

$  19,151,500

 

$  20,104,789

 

 

 

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

Accounts payable

$    1,478,924

 

$    3,046,563

Accrued compensation and benefits

429,620

 

731,744

Other accrued expenses and current liabilities

889,543

 

1,829,919

Short-term capital lease obligation

328,488

 

Income taxes payable

8,446

 

12,606

Accrued product warranty costs

187,234

 

198,666

Deferred revenue

381,116

 

519,139

Total Current Liabilities

3,703,371

 

6,338,637

 

 

 

 

OTHER LIABILITIES:

 

 

 

Long-term debt

2,878,683

 

2,594,209

Deferred rent liability

143,700

 

166,969

Convertible debt, net of discount of $460,404 in December

789,596

 

Deferred revenue, less current portion

81,656

 

148,553

Total Other Liabilities

3,893,635

 

2,909,731

 

 

 

 

TOTAL LIABILITIES

7,597,006

 

9,248,368

 

 

 

 

COMMITMENTS AND CONTINGENCIES

 

 

 

 

 

 

 

SHAREHOLDERS' EQUITY:

 

 

 

Series A Convertible Preferred Stock, $.001 par value

 

 

 

Authorized 1,000,000 shares; none issued

 

Common Stock, $.001 par value; 25,000,000 shares authorized;

 

 

 

issued and outstanding, respectively, 12,107,799 and 11,721,572

 

 

 

shares in December and 11,794,101 and 11,708,964 shares in June

11,722

 

11,709

Additional paid-in capital

12,589,289

 

11,798,443

Accumulated other comprehensive income (loss)

(24,278)

 

29,167

Accumulated deficit

(1,022,239)

 

(982,898)

Total Shareholders' Equity

11,554,494

 

10,856,421

 

 

 

 

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

$  19,151,500

 

$  20,104,789

 

See accompanying notes to condensed consolidated financial statements.

 

3

 



To Table of Contents

 

 

MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

 

Three Months Ended

December 31,

 

Six Months Ended

December 31,

 

2008

 

2007

 

2008

 

2007

 

 

 

 

 

 

 

 

NET REVENUES

$   5,156,705

 

$   5,685,477

 

$  10,909,110

 

$  12,116,367

 

 

 

 

 

 

 

 

COST OF GOODS SOLD:

 

 

 

 

 

 

 

Cost of goods sold, excluding depreciation and

amortization, product warranty, shipping and freight

2,551,580

 

2,567,505

 

5,203,804

 

5,526,609

Depreciation and amortization

139,627

 

153,293

 

257,116

 

300,300

Product warranty

227,330

 

199,234

 

441,499

 

411,351

Shipping and freight

116,141

 

163,136

 

263,766

 

330,708

Total cost of goods sold

3,034,678

 

3,083,168

 

6,166,185

 

6,568,968

 

 

 

 

 

 

 

 

GROSS PROFIT

2,122,027

 

2,602,309

 

4,742,925

 

5,547,399

 

 

 

 

 

 

 

 

OTHER COSTS AND EXPENSES:

 

 

 

 

 

 

 

Research and development

348,194

 

468,914

 

721,246

 

966,280

Selling, general and administrative, excluding

depreciation and amortization

2,495,540

 

2,876,776

 

5,248,447

 

5,568,822

Depreciation and amortization

92,467

 

95,160

 

186,400

 

184,555

Litigation settlement

 

 

(1,500,000)

 

Total other costs and expenses

2,936,201

 

3,440,850

 

4,656,093

 

6,719,657

 

 

 

 

 

 

 

 

INCOME (LOSS) FROM OPERATIONS

(814,174)

 

(838,541)

 

86,832

 

(1,172,258)

 

 

 

 

 

 

 

 

Interest expense

(125,159)

 

(7,637)

 

(227,899)

 

(16,137)

Interest income

53,235

 

8,689

 

101,710

 

25,179

Amortization of debt discount on convertible debt

(26,211)

 

 

(26,211)

 

 

 

 

 

 

 

 

 

LOSS BEFORE INCOME TAXES

(912,309)

 

(837,489)

 

(65,568)

 

(1,163,216)

Benefit for income taxes

395,572

 

352,330

 

26,227

 

490,899

 

 

 

 

 

 

 

 

NET LOSS

$     (516,737)

 

$     (485,159)

 

$     (39,341)

 

$     (672,318)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LOSS PER SHARE

 

 

 

 

 

 

 

Basic and diluted

$          (0.04)

 

$           (0.04)

 

$          (0.00)

 

$          (0.06)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE SHARES USED TO COMPUTE LOSS PER SHARE

 

 

 

 

 

 

 

Basic and diluted

11,721,467

 

11,576,357

 

11,719,283

 

11,523,930

 

See accompanying notes to condensed consolidated financial statements.

 

4

 



To Table of Contents

 

 

MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY AND

COMPREHENSIVE LOSS

SIX MONTHS ENDED DECEMBER 31, 2008

(UNAUDITED)

 

 

 

 

Common Stock

 

Additional

Paid-in

Capital

 

Accumulated

Deficit

 

Accumulated

Other

Comprehensive

Income (loss)

 

Total

Shareholders'

Equity

Shares

 

Amount

BALANCES, JUNE 30, 2008

11,708,964

 

$ 11,709

 

$ 11,798,443

 

$   (982,898)

 

$  29,167

 

$ 10,856,421

 

 

 

 

 

 

 

 

 

 

 

 

Components of comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

 

(39,341)

 

 

(39,341)

Cumulative translation adjustment

 

 

 

 

(53,445)

 

(53,445)

Total comprehensive loss

 

 

 

 

 

(92,786)

Fair value of warrants and beneficial

conversion discount on convertible note

 

 

422,660

 

 

 

422,660

Vested restricted stock units

12,608

 

13

 

(13)

 

 

 

Stock-based compensation expense

 

 

368,199

 

 

 

368,199

BALANCES, DECEMBER 31, 2008

11,721,572

 

$ 11,722

 

$ 12,589,289

 

$ (1,022,239)

 

$ (24,278)

 

$ 11,554,494

 

See accompanying notes to condensed consolidated financial statements.

 

5

 



To Table of Contents

 

 

MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

 

Six Months Ended

December 31,

 

2008

 

2007

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

Net loss

$      (39,341)

 

$    (672,318)

Adjustments to reconcile net loss to net cash used by operating activities:

 

 

 

Depreciation and amortization

471,108

 

508,275

Deferred income taxes

(26,227)

 

(490,899)

Tax benefits from employee stock options

 

125,058

Provision for inventory obsolescence

67,610

 

8,481

Provision for (recovery of ) bad debts

17,112

 

(4,134)

Stock-based compensation expense

363,416

 

221,337

Amortization of debt discount on convertible debt

26,211

 

Changes in operating assets and liabilities:

 

 

 

Accounts receivable

77,174

 

(326,512)

Inventories

1,957,369

 

(1,693,128)

Income taxes

(4,160)

 

88,916

Prepaid expenses and other current assets

(25,863)

 

(87,042)

Accounts payable

(1,625,183)

 

798,332

Accrued compensation and benefits

(302,124)

 

(165,702)

Other accrued expenses and current liabilities

(921,668)

 

836,080

Deferred rent liability

(23,268)

 

(33,460)

Deferred revenue

(204,920)

 

(75,913)

Net cash used by operating activities

(192,754)

 

(962,629)

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

Purchases of property and equipment

(597,482)

 

(246,417)

Net cash used in investing activities

(597,482)

 

(246,417)

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

Bank credit line net proceeds

284,474

 

155,220

Bank term loan repayments

 

(72,971)

Capital lease obligation repayments

(200,000)

 

Proceeds from issuance of subordinated convertible debt

1,250,000

 

Proceeds from issuance of common stock

 

243,518

Net cash provided by financing activities

1,334,474

 

325,767

Effect of exchange rate changes on cash and cash equivalents

(61,334)

 

NET INCREASE (DECREASE) IN CASH

482,904

 

(883,279)

 

 

 

 

CASH, BEGINNING OF PERIOD

236,571

 

1,808,285

 

 

 

 

CASH, END OF PERIOD

$      719,475

 

$      925,006

 

 

 

 

SUPPLEMENTAL CASH FLOW INFORMATION

 

 

 

Interest paid

$      111,447

 

$        16,191

Income taxes paid (refunded)

$          6,240

 

$     (213,974)

 

 

 

 

SUPPLEMENTAL DISCLOSURE OF NON-CASH TRANSACTIONS

 

 

 

Capital lease additions

$      528,488

 

$                 –

 

See accompanying notes to condensed consolidated financial statements.

 

6

 



To Table of Contents

 

 

MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

 

NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION

 

Nature of Business.   Media Sciences International, Inc. is a holding company which conducts its business through its operating subsidiaries. The Company is a manufacturer of business color printer supplies, which the Company distributes through an international network of dealers and distributors.

 

Basis of Presentation.   The condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”).  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to Article 8 of Rule S-X. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal, recurring adjustments) necessary for a fair presentation of the financial position, results of operations and cash flows for the periods indicated.  You should read these condensed consolidated financial statements in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2008, filed with the SEC on September 25, 2008. The June 30, 2008 consolidated balance sheet data was derived from audited consolidated financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America.

 

The consolidated financial statements include the accounts of Media Sciences International, Inc., a Delaware corporation, and its subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

 

The results of operations for the three and six months ended December 31, 2008 are not necessarily indicative of the results that may be expected for any other interim period or for the full year ending June 30, 2009.

 

As of December 31, 2008, there have been no significant changes to any of the Company’s accounting policies as set forth in the Annual Report on Form 10-K for the year ended June 30, 2008.

 

Accumulated Other Comprehensive Income (loss).   Other comprehensive income (loss) represents currency translation adjustments. Assets and liabilities of the Company’s United Kingdom and China subsidiaries have been translated at current exchange rates, and related revenues and expenses have been translated at average rates of exchange in effect during the period. The functional currency of the Company’s foreign subsidiaries is as follows: Media Sciences UK, Ltd., the British Pound, and Media Sciences (Dongguan) Company Limited, the Chinese Yuan. Foreign currency transaction gains and losses are recorded as a component of selling, general and administrative expense.

 

Reclassifications.   Certain prior period balances have been reclassified to conform to the current financial statement presentation. These reclassifications had no impact on previously reported results of operations or shareholders’ equity.

 

Estimates and Uncertainties.   The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s most significant estimates and assumptions made in the preparation of the financial statements relate to revenue recognition, accounts receivable reserves, inventory reserves, income taxes, warranty reserves, and certain accrued expenses. Actual results could differ from those estimates.

 

7

 



To Table of Contents

 

 

MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

 

NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION (CONTINUED)

 

Liquidity.   Over the next twelve months, the Company’s operations may require additional funds and it may seek to raise such additional funds through public or private sales of debt or equity securities, or securities convertible or exchangeable into such securities, strategic relationships, bank debt, lease financing arrangements, or other available means. No assurance can be provided that additional funding, if sought, will be available or, if available, will be on acceptable terms to meet the Company’s business needs. If additional funds are raised through the issuance of equity securities, stockholders may experience dilution, or such equity securities may have rights, preferences, or privileges senior to those of the holders of the Company’s common stock. If additional funds are raised through debt financing, the debt financing may involve significant cash payment obligations and financial or operational covenants that may restrict the Company’s ability to operate its business. An inability to fund its operations or fulfill outstanding obligations could have a material adverse effect on the Company’s business, financial condition and results of operations.

 

Income Taxes.   The Company recognizes deferred tax assets, net of applicable valuation allowances, related to net operating loss carry-forwards and certain temporary differences and deferred tax liabilities related to certain temporary differences. The Company recognizes a future tax benefit to the extent that realization of such benefit is considered to be more likely than not. This determination is based on projected taxable income and tax planning strategies. Otherwise, a valuation allowance is applied. To the extent that the Company’s deferred tax assets require valuation allowances in the future, the recording of such valuation allowances would result in an increase to its tax provision in the period in which the Company determines that such a valuation allowance is required.

 

Recent Accounting Pronouncements

 

In May 2008, the Financial Accounting Standards Board (“FASB”) issued SFAS No. 162, “The Hierarchy of Generally Accepted Accounting Principles.” This statement identifies the sources of accounting principles and the framework for selecting the principles to be used in the preparation of financial statements of nongovernmental entities that are presented in conformity with generally accepted accounting principles (GAAP) in the United States. The Company does not expect that this Statement will result in a change in any of its current accounting practices.

 

In April 2008, the FASB adopted FASB Staff Position SFAS No. 142-3, “Determination of the Useful Life of Intangible Assets,”, amending the factors that should be considered in developing renewal or extension assumptions used to determine the useful life of a recognized intangible asset under SFAS No. 142, “Goodwill and Other Intangible Assets.” This FASB Staff Position is effective for intangible assets acquired on or after July 1, 2009. The Company does not believe that the adoption of this standard will have a material effect on its financial condition or results of operations.

 

In September 2006, the FASB issued Statement No. 157, “Fair Value Measurements” (SFAS 157). SFAS 157 defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles, and expands disclosures about fair value measurements. In February 2008, the FASB issued Staff Position No. 157-1, “Application of FASB Statement No. 157 to FASB Statement No. 13 and Other Accounting Pronouncements That Address Fair Value Measurements for Purposes of Lease Classification or Measurement under Statement 13” (“FSP 157-1”) and Staff Position No. 157-2, “Effective Date of FASB Statement No. 157” (“FSP 157-2”). In October 2008, the FASB adopted FASB Staff Position No. 157-3 “Determining the Fair Value of a Financial Asset When the Market for That Asset Is Not Active” (“FSP 157-3”).

 

FSP 157-1 amends SFAS 157 to remove certain leasing transactions from its scope. FSP 157-2 delays the effective date of SFAS 157 for all non-financial assets and non-financial liabilities, except for items that are recognized or disclosed at fair value in the financial statements on a recurring basis (at least annually), until the Company’s fiscal year beginning July 1, 2009. The measurement and disclosure requirements related to financial assets and financial liabilities are effective for the Company beginning in the Company’s 2009 fiscal year beginning July 1, 2008.

 

8

 



To Table of Contents

 

 

MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

 

NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION (CONTINUED)

 

Recent Accounting Pronouncements

 

FSP 157-3 reaffirms that for financial assets fair value is an estimated exit price, and provides examples of how to estimate fair values when relevant observable data are not available.  It further clarifies that in disorderly markets, judgment is required when deciding to accept or reject market prices as evidence of fair value.  157-3 is immediately effective, including for prior periods, for which financial statements have not been issued. With regard to the remaining elements of SFAS 157, for which adoption is delayed under FSP 157-2, the Company continues to evaluate the impact adoption may have on its financial position and results of operations.

 

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities – Including an Amendment of FASB Statement No. 115” (“SFAS 159”). SFAS 159 permits all entities the option to measure many financial instruments and certain other items at fair value. If a company elects the fair value option for an eligible item, then it will report unrealized gains and losses on those items at each subsequent reporting date. SFAS 159 is effective for the Company is its fiscal year beginning July 1, 2008. The adoption of SFAS No. 159 did not have a material effect on the Company’s consolidated financial position, results of operations or cash flows.

 

NOTE 2 – CONDENSED CONSOLIDATED BALANCE SHEET COMPONENTS

 

 

 

December 31,

2008

(Unaudited)

 

June 30, 2008

Accounts receivable, net

 

 

 

 

Accounts receivable

 

$3,066,107

 

$3,177,516

Allowance for doubtful accounts

 

(42,432)

 

(95,000)

 

 

$3,023,675

 

$3,082,516

Inventories

 

 

 

 

Raw materials

 

$2,895,144

 

$3,281,742

Finished goods

 

4,947,622

 

6,513,609

Less: reserves for obsolescence

 

(646,522)

 

(578,912)

 

 

$7,196,244

 

$9,216,439

 

 

 

 

 

Property and Equipment, net

Useful Lives

 

 

 

Equipment

3 – 7 years

$2,638,536

 

$2,074,649

Furniture and fixtures

7 years

578,672

 

578,672

Automobiles

5 years

30,434

 

30,434

Leasehold improvements

5 years

878,104

 

878,104

Tooling and molds

3 years

2,821,146

 

2,780,173

Construction-in-progress

 

1,110,917

 

595,006

 

 

8,057,809

 

6,937,038

Less: Accumulated depreciation and amortization

 

4,930,378

 

4,464,468

 

 

$3,127,431

 

$2,472,570

 

 

 

 

 

Goodwill and other intangible assets, net

 

 

 

 

Goodwill

 

$3,965,977

 

$3,965,977

Other

1-5 years

46,000

 

46,000

 

 

4,011,977

 

4,011,977

Less: Accumulated amortization

 

427,746

 

427,746

 

 

$3,584,231

 

$3,584,231

 

 

9

 



To Table of Contents

 

 

MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

 

NOTE 3 – DEBT

 

Bank Debt

 

The Company’s indebtedness under secured commercial loan agreements consisted of the following:

 

 

 

December 31, 2008

 

June 30, 2008

 

 

(Unaudited)

 

 

 

Short-term capital lease obligation

$      328,488

 

$                 

 

 

 

 

 

 

Bank term notes

$  1,500,000

 

$  1,500,000

 

Bank line of credit

1,378,683

 

1,094,209

 

Less: current maturities

 

 

Long-term debt

$  2,878,683

 

$  2,594,209

 

Total bank debt

$  3,207,171

 

$  2,594,209

 

On February 12, 2008, the Company entered into an agreement with Sovereign Bank for a three year revolving line of credit for up to $8,000,000. As amended, the advance limit under the line of credit is the lesser of: (a) $8,000,000; or (b) up to 80% of eligible accounts receivable plus up to the lesser of: (i) $3,000,000; or (ii) 50% of eligible inventory; or (iii) 60% of the maximum amount available to be advanced under the line. At December 31, 2008, the Company had approximately $261,000 of undrawn availability under its credit line.

 

The line of credit is collateralized by a first priority security interest in substantially all of the Company’s U.S. based assets. Proceeds were drawn down under this line to repay all revolving and term debt extended by the Company’s former bank. On May 14, 2008 the Company entered into an amendment to the loan agreement that amended the range of interest rates applicable to the Company’s borrowings. As amended, under a prime rate option, the interest rate can vary from the bank’s prime rate to its prime rate plus 1%, and, under a LIBOR rate option, the interest rate can vary from LIBOR plus 225 basis points to LIBOR plus 275 basis points. Both the term note and the line of credit bear interest at the bank’s Prime Rate plus 1% (4.25% at December 31, 2008) and require payments of interest only through the facility’s three year term. No principal payments are required under the term note or line of credit until the facility matures on February 11, 2011; subject to renewal or extension by the parties.

 

The applicable interest rate on the revolving loan and term loans extended under the agreement varies based upon certain financial criteria. The revolving loan may be converted into one or more term notes upon mutual agreement of the parties. On February 12, 2008, the Company entered into a three-year term note with the bank in the amount of $1,500,000.

 

The Company’s current and former credit facilities are/were subject to financial covenants. Current financial covenants include monitoring a ratio of debt to tangible net worth and a fixed charge coverage ratio, as defined in the loan agreements. At June 30, 2008, the Company was not in compliance with the financial covenants, which were waived by the Company’s bank via an amendment dated September 22, 2008. As a result of a cross default and collateralization provision associated with its former debt facility, the Company agreed to refinance certain operating leases held by an affiliate of the former bank. Under terms of a separate waiver and amendment with this leasing affiliate, the Company received an extension of time to refinance or payoff the lease obligation until March 31, 2009. At December 31, 2008, the remaining obligation under the agreement was $328,488. Under the terms of this amendment, the Company agreed to make six lease payments of $50,000 per month between October 2008 and March 2009 and refinance or otherwise payoff any remaining balance on or before March 31, 2009. Upon full satisfaction of this obligation the Company will obtain title to the leased equipment. Based on the amended lease terms, which include an agreed upon interest charge of prime plus 2.5% per annum, the remaining balance at March 31, 2009 will be approximately $245,000. This obligation may be refinanced or otherwise prepaid at anytime without penalty. The Company was in compliance with all of its financial covenants as of December 31, 2008.

 

10

 



To Table of Contents

 

 

MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

 

NOTE 3 – DEBT (CONTINUED)

 

Convertible Debt

 

On September 24, 2008, the Company completed a $1,250,000 convertible debt financing with MicroCapital Fund, LP and MicroCapital Fund, Ltd. (“MicroCapital”). The Company issued three year notes, bearing interest at 10% payable quarterly and convertible into shares of the Company’s common stock at $1.65 per share. The Company also issued (a) five year warrants to purchase 378,787 shares of the Company’s common stock at $1.65 per share, and (b) three year warrants allowing MicroCapital to repeat its investment up to $1,250,000 on substantially the same terms and conditions. To date, the proceeds of this financing have been used to fund the capital expenditure and working capital requirements associated with its China based manufacturing operations.

 

The Company may call the three year warrants, subject to MicroCapital’s preemptive right to exercise, at a redemption price of $0.001 per share. The three year warrants may only be called after the earlier of 90 days after the registration statement is effective or June 24, 2009 if the closing sale price of the Company’s common stock equals or exceeds $1.83 per share for at least 24 trading days within a 30 trading day period; this threshold price increases by $0.02 per share starting with the end of the following calendar month. MicroCapital has agreed to limit the number of shares that may be acquired upon the exercise of warrants by them to 4.999% of the Company’s outstanding shares of common stock, which may be waived by MicroCapital upon 60 days notice. MicroCapital has also agreed to limit the number of shares that may be acquired upon the exercise the warrants to 9.999% of the Company’s outstanding shares of common stock; this limit may not be waived. The Company agreed that within sixty days from the date of issuance of the note and warrants that it would file a registration statement with the SEC covering the resale of the shares of the Company's stock issuable upon conversion of the note and the exercise of the warrants. On November 7, 2008, the Company fulfilled this commitment with the filing of an S-3 registration statement covering the shares potentially issuable as a result of the transaction.

 

The transaction was recorded in accordance with EITF 00-27 “Application of Issue #98-5 to Certain Convertible Instruments” and EITF 98-5, "Accounting for Convertible Securities with Beneficial Conversion Features or Contingently Adjusted Conversion Ratios", on a relative fair value basis. The $486,615 fair value of the warrants and the debt’s beneficial conversion feature was recorded to equity and as a debt discount to the value of the convertible note. This discount will be amortized using the effective interest method over the three year term of the convertible note. Amortization of debt discount on this convertible note payable amounted to $26,211 for the three months ended December 31, 2008. The remaining unamortized discount was $460,404 at December 31, 2008. In connection with this transaction, the Company also recognized a $63,955 increase in its deferred tax liabilities reflecting the non-deductible nature of future debt discount amortization that will result from the value of the beneficial conversion feature. The elements of the debt discount and corresponding value recorded to additional paid-in capital were as follow:

 

Transaction Element

Value

Warrants issued

$ 327,524

Beneficial conversion feature of convertible debt issued

159,091

Debt discount

$ 486,615

Less: deferred tax liability resulting from beneficial conversion feature

(63,955)

Value recorded to additional paid-in capital

$ 422,660

 

 

11

 



To Table of Contents

 

 

MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

 

NOTE 4 – LOSS PER SHARE

 

Basic loss per share is computed using the weighted average number of common shares outstanding. Diluted loss per share is computed using the weighted average number of common shares outstanding as adjusted for the incremental shares attributable to outstanding options, restricted stock units and warrants to purchase common stock.

 

The following table sets forth the computation of the basic and diluted loss per share:

 

 

Three Months Ended

December 31,

 

Six Months Ended

December 31,

 

2008

 

2007

 

2008

 

2007

Numerator for basic and diluted:

 

 

 

 

 

 

 

Net loss

$     (516,737)

 

$    (485,159)

 

$     (39,341)

 

$    (672,318)

 

 

 

 

 

 

 

 

Denominator :

 

 

 

 

 

 

 

For basic loss per common share –

weighted average shares outstanding

11,721,467

 

11,576,357

 

11,719,283

 

11,523,930

Effect of dilutive securities - stock options,

restricted stock units and warrants

 

 

 

For diluted loss per common share –

weighted average shares outstanding adjusted

for assumed exercises

11,721,467

 

11,576,357

 

11,719,283

 

11,523,930

 

 

 

 

 

 

 

 

Basic loss per share

$          (0.04)

 

$          (0.04)

 

$         (0.00)

 

$          (0.06)

 

 

 

 

 

 

 

 

Diluted loss per share

$          (0.04)

 

$          (0.04)

 

$         (0.00)

 

$          (0.06)

 

 

The following options and warrants to purchase common stock were excluded from the computation of diluted loss per share for the three and six months ended December 31, 2008 and 2007 because their exercise price was greater than the average market price of the common stock or as a result of the Company’s net loss for those periods:

 

 

Three Months Ended

December 31,

 

Six Months Ended

December 31,

 

2008

 

2007

 

2008

 

2007

Anti-dilutive options and warrants

791,605

 

347,025

 

786,105

 

347,025

 

12

 



To Table of Contents

 

 

MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

 

NOTE 5 – STOCK-BASED COMPENSATION

 

The effect of recording stock-based compensation for the three and six months ended December 31, 2008 and 2007 was as follows:

 

 

 

Three Months

Ended

December 31,

2008

 

Three Months

Ended

December 31,

2007

 

Six Months

Ended

December 31,

2008

 

Six Months

Ended

December 31,

2007

 

Stock-based compensation expense by type of award:

 

 

 

 

 

 

 

 

Employee stock options

$   83,634

 

$   41,313

 

$ 162,346

 

$   71,928

 

Non-employee director stock options

16,738

 

38,993

 

71,299

 

38,993

 

Non-employee restricted stock units

7,350

 

9,670

 

14,700

 

19,341

 

Employee restricted stock units

61,425

 

47,522

 

140,756

 

94,012

 

Non-employee director restricted stock units

35,848

 

 

 

35,848

 

 

 

Forfeiture rate adjustment

 

 

(56,751)

 

 

Amounts capitalized as inventory

3,010

 

(773)

 

(4,782)

 

(2,937)

 

Total stock-based compensation expense

$ 208,005

 

$ 136,725

 

$ 363,416

 

$ 221,337

 

Tax effect of stock-based compensation recognized

(78,721)

 

(49,864)

 

(163,154)

 

(79,184)

 

Net effect on net loss

$ 129,284

 

$   86,861

 

$ 200,262

 

$ 142,153

 

 

 

 

 

 

 

 

 

 

Excess tax benefit effect on:

 

 

 

 

 

 

 

 

Cash flows from operations

$            

 

$            

 

$            

 

$            

 

Cash flows from financing activities

$            

 

$            

 

$            

 

$            

 

Effect on loss per share:

 

 

 

 

 

 

 

 

Basic

$       0.01

 

$        0.01

 

$       0.02

 

$       0.01

 

Diluted

$       0.01

 

$        0.01

 

$       0.02

 

$       0.01

 

 

During the three months ended December 31, 2008, the Company did not grant any stock options. During the six months ended December 31, 2008, the Company granted 435,047 stock options with an estimated total grant-date fair value of $271,182 after estimated forfeitures. During the three months ended December 31, 2008, the Company granted 156,764 shares of restricted stock with a grant date fair value of $201,260 after estimated forfeitures. During the six months ended December 31, 2008, the Company granted 313,698 shares of restricted stock with a grant date fair value of $442,123 after estimated forfeitures.

 

During the quarter ended September 30, 2008, the Company reviewed its forfeiture rate experience associated with historic stock-based compensation grants. In doing so, it was determined that an increase in its forfeiture rate estimates were appropriate. In connection with this revision in estimate, the Company recognized a non-recurring cumulative effect pretax benefit in the amount of $56,751during the quarter ended September 30, 2008.

 

As of December 31, 2008, the unrecorded deferred stock-based compensation balance was $999,748 after estimated forfeitures and will be recognized over an estimated weighted average amortization period of about 1.8 years.

 

13

 



To Table of Contents

 

 

MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

 

NOTE 5 – STOCK-BASED COMPENSATION (CONTINUED)

 

Valuation Assumptions

 

The Company estimates the fair value of stock options using a Black-Scholes option-pricing model, consistent with the provisions of SFAS No. 123(R) and SEC Staff Accounting Bulletin (“SAB”) No. 107. The fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model and the straight-line attribution approach with the following weighted-average assumptions:

 

 

Three Months Ended

December 31,

 

Six Months Ended

December 31,

 

2008 (a)

 

2007

 

2008

 

2007

 

 

 

 

 

 

 

 

Risk-free interest rate

 

4.2%

 

2.8%

 

4.2%

Dividend yield

 

0.0%

 

0.0%

 

0.0%

Expected stock price volatility

 

59%

 

58%

 

59%

Average expected life of options

 

4.3 years

 

3.2 years

 

4.3 years

 

 

 

 

 

 

 

 

(a)    No stock options were granted during the three months ended December 31, 2008.

 

SFAS No. 123(R) requires the use of option pricing models that were not developed for use in valuing employee stock options. The Black-Scholes option-pricing model was developed for use in estimating the fair value of short-lived exchange traded options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require the input of highly subjective assumptions, including the option’s expected life and the price volatility of the underlying stock. The expected stock price volatility assumption was determined using a blend of the Company’s historic volatility and that of a peer group of technology-based manufacturing companies with similar attributes, including market capitalization, annual revenues, and debt leverage. The Company places limited reliance on the historic volatility of its common stock given the substantial reorganization of the Company in 2005. In 2005, the Company discontinued the electronic pre-press sales and service operations of its Cadapult Graphic Systems subsidiary.  Historically, these discontinued operations represented a significant portion of the Company’s operations. These discontinued operations were also materially different, in many respects, from the Company’s present technology-based manufacturing business. For these reasons, the Company determined that historic peer group volatility was more reflective of market conditions and a better indicator of expected volatility than its own historic volatility for years prior to 2005.

 

The Company uses the simplified method suggested by the SEC in SAB 107 for determining the expected life of the options. Under this method, the Company calculates the expected term of an option grant by averaging its vesting and contractual term. Based on studies of the Company’s historic actual option terms, compared with expected terms predicted by the simplified method, the Company has concluded that the simplified method yields materially accurate expected term estimates. The Company estimates its applicable risk-free rate based upon the yield of U.S. Treasury securities having maturities similar to the estimated term of an option grant, adjusted to reflect it’s continuously compounded “zero-coupon” equivalent.

 

14

 



To Table of Contents

 

 

MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

 

NOTE 5 – STOCK-BASED COMPENSATION (CONTINUED)

 

Equity Incentive Program

 

The Company’s equity incentive program is a broad-based, long-term retention program that is intended to attract and retain qualified management and technical employees, and align stockholder and employee interests.  The equity incentive program presently consists of three plans (the “Plans”): the Company's 1998 Incentive Plan, as Amended and Restated (the “1998 Plan”); the Company’s 2006 Stock Incentive Plan, as Amended and Restated (the “2006 Plan”); and the Company’s 2009 Stock Incentive Plan (the “2009 Plan”). Under these Plans, non-employee directors, officers, key employees, consultants and all other employees may be granted options to purchase shares of the Company’s stock, restricted stock units and other types of equity awards. Under the equity incentive program, stock options generally have a vesting period of three to five years, are exercisable for a period not to exceed ten years from the date of issuance and are not granted at prices less than the fair market value of the Company’s common stock at the grant date.  Restricted stock units may be granted with varying service-based vesting requirements.

 

Under the Company’s 1998 Plan, 1,000,000 common shares are authorized for issuance through awards of options or other equity instruments. As of December 31, 2008, there are no common shares remaining available for future issuance under the 1998 Plan. The 1998 Plan expired on June 17, 2008. Under the Company’s 2006 Plan, 1,000,000 common shares are authorized for issuance through awards of options or other equity instruments.  As of December 31, 2008, 100,649 common shares remain available for future issuance under the 2006 Plan. Under the Company’s 2009 Plan, 1,250,000 common shares are authorized for issuance through awards of options or other equity instruments.  As of December 31, 2008, 1,250,000 common shares remain available for future issuance under the 2009 Plan.

 

The following table summarizes the combined stock option plan and non-plan activity for the indicated periods:

 

 

 

Number of

Shares

 

Weighted

Average

Exercise Price

Balance outstanding at June 30, 2008

899,894

 

$3.86

Six months ended December 31, 2008:

 

 

 

Options granted

435,047

 

2.03

Options exercised

 

Options cancelled/expired/forfeited

(177,784)

 

2.43

Balance outstanding at December 31, 2008

1,157,157

 

$3.39

 

The options outstanding and exercisable at December 31, 2008 were in the following exercise price ranges:

 

 

Options Outstanding

Options Exercisable

Range of

Exercise

Prices

Number

Outstanding

Weighted

Average

Remaining

Contractual

Life-Years

Weighted

Average

Exercise

Price

 

Number

Vested and

Exercisable

Weighted

Average

Exercise

Price

 

 

 

 

 

 

 

$0.43 to $0.85

28,200

4.3

$0.59

 

28,200

$0.59

$1.00 to $2.00

515,399

4.6

1.99

 

125,352

1.13

$2.01 to $6.33

613,558

5.8

4.70

 

380,991

4.08

 

1,157,157

5.2

$3.39

 

534,543

$3.21

 

At December 31, 2008, none of the Company’s exercisable options were in-the-money. Accordingly, all outstanding and exercisable options at that date had no aggregate intrinsic value. No options were exercised during the three months ended December 31, 2008.

 

15

 



To Table of Contents

 

 

MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

 

NOTE 5 – STOCK-BASED COMPENSATION (CONTINUED)

 

The weighted average grant date fair value of options, as determined under SFAS No. 123(R), granted during the six months ended December 31, 2008 and 2007 was $0.84 and $2.79 per share, respectively. No stock options were granted during the three months ended December 31, 2008.

 

The Company settles employee stock option exercises with newly issued common shares.

 

Restricted Stock Units

 

During the three months ended December 31, 2008, the Company’s Board of Directors approved the grant of 133,335 shares of restricted stock units to non-employee directors and 23,429 shares of restricted stock units to an employee. These restricted stock units vest over one year from the grant date for non-employee directors and over two years from the grant date for the employee. The value of the restricted stock units is based on the closing market price of the Company’s common stock on the date of award. The total grant date fair value of the restricted stock units granted during the three months ended December 31, 2008 was $201,260 after estimated forfeitures. Stock-based compensation cost for restricted stock units for the six months ended December 31, 2008 was $167,500, net of adjustment for the change in estimate associated with forfeiture rates.

 

As of December 31, 2008, there was $432,310 of total unrecognized deferred stock-based compensation after estimated forfeitures related to non-vested restricted stock units granted under the Plans.  That cost is expected to be recognized over an estimated weighted average period of 1.4 years.

 

The following table summarizes the Company’s restricted stock unit activity for the indicated periods: 

 

 

Number of

Shares

 

Grant Date

Fair Value

 

Weighted

Average Grant

Date Fair Value

Per Share

Balance unvested at June 30, 2008

85,137

 

$    423,538

 

$        4.97

 

 

 

 

 

 

Six months ended December 31, 2008:

 

 

 

 

 

Restricted stock units granted

313,698

 

524,086

 

1.67

Restricted stock units vested

(12,608)

 

(35,545)

 

2.82

Restricted stock units cancelled/forfeited

 

 

Balance unvested at December 31, 2008

386,227

 

$    912,079

 

$        2.36

 

 

16

 



To Table of Contents

 

 

MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

 

NOTE 6 – ACCRUED PRODUCT WARRANTY COSTS

 

The Company provides a warranty for all of its consumable supply products and for its INKlusive printer program. The Company’s warranty stipulates that it will pay reasonable and customary charges for the repair of a printer needing service as a result of using the Company’s products. The Company estimates the costs that may be incurred and records a liability in the amount of such costs at the time product revenue is recognized. Factors that may affect the warranty liability and expense include the number of units shipped to customers, historical and anticipated rates of warranty claims and cost per claim. The Company periodically assesses the adequacy of the recorded warranty liability and adjusts the amount as necessary. These expenses are classified as a separately captioned item in cost of goods sold.

 

Changes in accrued product warranty costs for the three and six months ended December 31, 2008 and 2007 were as follows:

 

 

Three Months Ended

December 31,

 

Six Months Ended

December 31,

 

2008

 

2007

 

2008

 

2007

Accrued product warranty costs

at the beginning of the period

$  205,563

 

$  202,412

 

$  198,666

 

$  192,707

 

 

 

 

 

 

 

 

Warranties accrued during the period

227,330

 

199,234

 

441,499

 

411,351

Warranties settled during the period

(245,659)

 

(197,751)

 

(452,931)

 

(400,163)

Net change in accrued warranty costs

(18,329)

 

1,483

 

(11,432)

 

11,188

 

 

 

 

 

 

 

 

Accrued product warranty costs

at the end of the period

$  187,234

 

$  203,895

 

$  187,234

 

$  203,895

 

 

NOTE 7 – RESEARCH AND DEVELOPMENT

 

Research and product development costs, which consist of salary and related benefits costs of the Company’s technical staff, as well as product development costs including research of existing patents, conceptual formulation, design and testing of product alternatives, and construction of prototypes, are expensed as incurred. It also includes indirect costs, including facility costs based on the department’s proportionate share of facility use. For the three and six months ended December 31, 2008, the Company’s research and product development costs were $348,194 and $721,246, respectively. For the three and six months ended December 31, 2007, the Company’s research and product development costs were $468,914 and $966,280, respectively.

 

 

NOTE 8 – ADVERTISING EXPENSES

 

Advertising expenses are deferred until the first use of the advertising. Deferred advertising costs at December 31, 2008 and 2007 totaled $15,276 and $79,460, respectively. Advertising expense for the three months ended December 31, 2008 and 2007 amounted to $180,559 and $191,463, respectively. Advertising expense for the six months ended December 31, 2008 and 2007 amount to $392,206 and $382,691, respectively.

 

17

 



To Table of Contents

 

 

MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

 

NOTE 9 – LITIGATION AND CONTINGENCIES

 

On June 23, 2006, Xerox Corporation filed a patent infringement lawsuit in the United States District Court, for the Southern District of New York, Case No. 06CV4872, against Media Sciences International, Inc. and Media Sciences, Inc., alleging that the Company’s solid inks designed for use in the Xerox Phaser 8500 and 8550 printers infringe four Xerox-held patents related to the shape of the ink sticks in combination with the Xerox ink stick feed assembly. The suit seeks unspecified damages and fees. In the Company’s answer and counterclaims in this action, it denied infringement and it seeks a finding of invalidity of the Xerox patents in question. The Company also submitted counterclaims against Xerox for breach of contract and violation of U.S. antitrust laws, seeking treble damages and recovery of legal fees. On September 14, 2007, the court denied Xerox’s motion to dismiss the antitrust counterclaims brought by the Company. Pre-trial discovery on the infringement action was completed in September 2007. Pre-trial discovery on the Company’s antitrust action was completed in July 2008. Both actions, which the court has ruled will be tried together, may be heard in the fall or winter of 2009. The loss of all or a part of this lawsuit could have a material adverse affect on our results of operations and financial position. The Company believes that its inks do not infringe any valid U.S. patents and therefore it has meritorious grounds for success in this case. The Company intends to vigorously defend these allegations of infringement. There can be no assurance, however, that the Company will be successful in its defense of this action. Proceeds of this suit, if any, will be recorded in the period when received.

 

In May 2005, the Company filed suit in New Jersey state court against its former insurance broker for insurance malpractice. This litigation was settled in August 2008. Under the settlement, Media Sciences received proceeds of $1,500,000. Proceeds of this settlement are recognized in the Company’s results of operations. The settlement is recorded as a reduction to operating expense during the quarter ended September 30, 2008. The settlement received represents a recovery of legal fees incurred to pursue the action and a partial recovery of product warranty expense the Company incurred during its fiscal 2002 year.

 

Other than the above, as at December 31, 2008, the Company was not a party to any material pending legal proceeding, other than ordinary routine litigation incidental to its business.

 

18

 



To Table of Contents

 

 

ITEM 2.  

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

FORWARD LOOKING STATEMENTS

 

Our disclosure and analysis in this report contain forward-looking information, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, about our financial results and estimates, business prospects and products in development that involve substantial risks and uncertainties. You can identify these statements by the fact that they do not relate strictly to historic or current facts. These forward-looking statements use terms such as "believes," "expects," "may", "will," "should," "anticipates," "estimate," "project," "plan," or "forecast" or other words of similar meaning relating to future operating or financial performance or by discussions of strategy that involve risks and uncertainties.   From time to time, we also may make oral or written forward-looking statements in other materials we release to the public.  These forward-looking statements are based on many assumptions and factors, and are subject to many conditions, including, but not limited to, our continuing ability to obtain additional financing, dependence on contracts with suppliers and major customers, competitive pricing for our products, demand for our products, changing technology, our introduction of new products, industry conditions, anticipated future revenues and results of operations, retention of key officers, management or employees, prospective business ventures or combinations and their potential effects on our business.  Our actual results, performance or achievements could differ materially from the results expressed in, or implied by, these forward-looking statements. Forward-looking statements are made based upon management's current expectations and beliefs concerning future developments and their potential effects upon our business.

 

We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans and assumptions. We cannot predict whether future developments affecting us will be those anticipated by management, and there are a number of factors that could adversely affect our future operating results or cause our actual results to differ materially from the estimates or expectations reflected in such forward-looking statements.  Factors that might cause or contribute to such differences include, but are not limited to, those discussed in this section and those set forth in Item 6, “Factors Affecting Results Including Risks and Uncertainties” included in our Form 10-K for the year ended June 30, 2008, filed September 25, 2008.  You should carefully review these risks and also review the risks described in other documents we file from time to time with the SEC.  You are cautioned not to place undue reliance on these forward-looking statements. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise.

 

You should read the following discussion and analysis in conjunction with the information set forth in the unaudited financial statements and notes thereto, included elsewhere herein, and the audited financial statements and the notes thereto, included in our Form 10-K for the year ended June 30, 2008, filed September 25, 2008.

 

 

EXECUTIVE SUMMARY

 

Media Sciences International, Inc. is the leading independent manufacturer of color toner cartridges and solid ink sticks for business color printers. Our products are distributed through an international network of dealers and distributors.

 

Media Sciences experienced a disappointing and difficult quarter.  The deepening economic recession and turbulence in the currency markets adversely affected our operating results and financial position. The global recession impacts our business by slowing our expected revenue growth and generating price pressure.  The sudden strong dollar versus the Euro and the British pound impacted our revenue and margins.  Our value proposition is stronger at a time when companies all over the world have an increased motivation to cut costs.  We are seeing some encouraging signs of corporate activity in assessing lower printing procurement options.  At the same time, the quarter saw a contraction across the board in November and December, as the entire distribution supply chain reduced inventory levels.  This contraction does appear to correlate with both the experience of our customers and what we saw from other industry participants, including our vendors and OEM competitors. While we experienced a nominally higher level of gross revenue and product sales volumes, an increased level of customer rebates and the revenue impact resulting from the strong U.S. Dollar, our net revenues for the three months ended December 31, 2008, as compared to the same period last year, decreased by $528,000 or 9% from $5,685,000 to $5,157,000.  

 

19

 



To Table of Contents

 

 

During the quarter, our reported net revenues, margins and net results were adversely affected by devaluation of the European currencies relative to the U.S. dollar. Versus the average exchange rates prevailing during our fiscal first quarter ended September 30, 2008, the British Pound and the Euro, respectively, declined 22% and 11% during the three months ended December 31, 2008. These significant declines reduced our reported net revenues by about $261,000 during the quarter, on a constant currency basis. The financial impact of this flowed directly through our gross profit, adversely impacting our gross margin by about 280 basis points. Further, the devaluation of the Pound and Euro resulted in the realization of currency exchange losses in the amount of $186,000 for the quarter, in addition to the $100,000 we reported for the prior quarter ended September 30, 2008. These realized currency exchange losses are included in our reported selling, general and administrative expense.

 

All told, the devaluation of the Pound and Euro adversely impacted our reported operating pretax results by about $447,000 ($268,000 after tax or about $0.02 per share) for the three months and about $547,000 ($328,000 after tax or about $0.03 per share) for the six months ended December 31, 2008. In response to this precipitous decline in currency values, we competitively evaluated and implemented increases to our Pound and Euro denominated prices. These price changes, effective January 1, 2009, are estimated to address about 60% to 70% of the U.S. dollar translated revenue impact of the devaluation experienced during the quarter. In response to our planned increase in European pricing, which was announced in early December, we saw some evidence of forward buying by our affected customers: European net revenues represented 29% of our consolidated net revenues during the quarter, as versus 19% in the preceding quarter (typically a slower seasonal period for European sales), and 22% of European net revenues represented in our prior fiscal year. Overall, we do anticipate that this forward buying will affect our fiscal third quarter European revenues.

 

We, like many other global companies, must operate in an environment of greater general uncertainty. We certainly believe that in this current recessionary period the theme of heightened emphasis on corporate cost reduction does play well to our strengths as a quality and value alternative to the OEM product. On this theme, we are seeing a greater level of evaluation and proposal activity from corporate accounts. However, to date this activity has not materialized into significant incremental revenue. On the other hand, corporate headcount reductions and a reduced level of economic activity are expected to adversely impact color consumable consumption through fewer pages printed and greater substitution with less expensive monochrome printing.

 

Additional Cost Reduction Efforts. The further deterioration of the economic climate combined with our results through the quarter prompted us to take further actions to reduce our operating costs. In addition to our cost reduction plan implemented in our fiscal first quarter, we have implemented or are implementing the following additional cost cutting measures:

 

An additional 7% reduction in force, on top of the approximate 20% staff reduction implemented in July. This additional headcount reduction was implemented in early January 2009. These headcount reductions are expected to help us realize an additional annual run-rate improvement in our pretax operating results of about $650,000 and an improvement in our operating cash flows of about $620,000. Severance costs associated with these staff reductions were not material.

A company-wide 10% salary, wage and bonus concession until certain profitability measures are achieved over a contiguous six-month period. This temporary measure was announced in early January 2009 and went into effect in late January 2009. This temporary measure is expected to generate about $450,000 in annualized run-rate savings.

Our Directors waived their cash compensation effective October 1, 2008 until they determine the present economic uncertainties facing the company have passed. This temporary action is expected to generate about $123,000 in annualized run-rate savings and benefitted the current quarter by about $31,000.

Our China manufacturing facility is complete and ready for production.  However, given the economic climate we are evaluating the ongoing and likely increased costs of operating the facility versus the short term benefits, which are expected to be primarily operational in nature.  We are considering a range of options including, but not limited to, deferring commercial production at the facility, conversion of the operation into a joint venture, closure, and monetizing our investment. The process associated with evaluating these options may take a number of months to complete, during which time we are unlikely to start any commercial production at the facility.

The Company is also pursuing other cost reduction efforts, including concessions from its landlords and other vendors.

 

20

 



To Table of Contents

 

 

These new cost reduction efforts are expected to help us realize additional savings of about $1,200,000 on an annualized run-rate pretax and cash basis. About $600,000 of these new annualized cost savings are from temporary measures which will cease after certain profitability measures are achieved over a contiguous six-month period. These new cost reduction efforts are in addition to the cost reduction plan we implemented in July of 2008. Five months into the July cost reduction plan, we continue to track favorably with our original plan to realize run-rate pretax GAAP cost savings, versus our run rate at the end of our 2008 fiscal year, of about $1,600,000 and about $1,900,000 on a cash flow basis.

 

Inventory Management Initiative. Our multi-faceted plan to better manage our toner-based product inventories and supply chain was implemented in July 2008. The plan integrates detailed SKU level sales forecasting with statistical modeling that accounts for demand variability based on historic order volatility. Other elements of the plan include a reduction in minimum order quantities through our providing vendors with rolling forecasts of our production needs. Although we achieved in five months our preliminary twelve month goal of $2,000,000 in inventory reductions, we continue to work on reducing our inventory levels further over the remainder of the fiscal year. During the six month ended December 31, 2008, we had achieved a $2,020,000 or a 22% reduction in inventories from $9,216,000 at June 30, 2008 to $7,196,000. Based on these quarter end inventory levels, which include raw materials, we have achieved a 46 day or 16% reduction in our days in inventory from 292 days at June 30, 2008 to 246 days at December 31, 2008.

 

Analysis of Second Quarter 2009 Results of Operations

 

The following items significantly impacted our reported results of operations for the three and six months ended December 31, 2008. Collectively, for the three months ended December 31, 2008, these items reduced our reported pretax income by $1,078,000, net income by about $650,000 and earnings per share by about $0.06, fully diluted. for the six months ended December 31, 2008, these items reduced our reported pretax income by $1,816,000, net income by about $1,072,000 and earnings per share by about $0.09, fully diluted.

 

Foreign Currency Devaluation – As described more fully above, significant rapid declines in British Pound and Euro exchange rates during the quarter adversely impacted our reported results as summarized below:

 

(a)

Reduced both our reported net revenues and gross profit by about $261,000 and adversely impacting our gross margin by about 280 basis points.

 

(b)

Resulted in the realization of currency exchange losses in the amount of $186,000 for the quarter, in addition to the $100,000 we reported for the prior quarter ended September 30, 2008.

All told, the devaluation of the Pound and Euro adversely impacted our reported operating pretax results by about $447,000 ($268,000 after tax or about $0.02 per share) for the three months and about $547,000 ($328,000 after tax or about $0.03 per share) for the six months ended December 31, 2008. In the year ago three and six months ended December 31, 2007, we had no material foreign exchange gains or losses as the Company did not begin to sell in euro or pound denominated transactions until late in its fiscal second quarter ending December 31, 2007.

Business Formation and Start-up Costs – For the three and six months ended December 31, 2008, formation and start-up costs associated with our manufacturing operations in China totaled $344,000 (about $206,000 after tax or about $0.02 per share) and $643,000 (about $386,000 after tax or about $0.03 per share), respectively. In the prior fiscal year, formation and start-up costs associated with our manufacturing operations in China totaled $196,000 (about $118,000 after tax or about $0.01 per share) for the three months and $346,000 (about $208,000 after tax or about $0.02 per share) for the six months ended December 31, 2007.

Litigation Costs – For the three and six months ended December 31, 2008, litigation costs totaled $79,000 of expense (about $47,000 after tax or about $0.00 per share) and $263,000 (about $158,000 after tax or about $0.01 per share), respectively. In the prior fiscal year, litigation costs totaled $352,000 (about $211,000 after tax or about $0.02 per share) for the three months and $593,000 (about $356,000 after tax or about $0.03 per share) for the six months ended December 31, 2007.

 

21

 



To Table of Contents

 

 

Stock-Based Compensation – For the three and six months ended December 31, 2008, our non-cash stock-based compensation expense recognized under SFAS No. 123(R) totaled $208,000 (about $129,000 after tax or about $0.01 per share) and $363,000 (about $200,000 after tax or about $0.02 per share), respectively. In the prior fiscal year, non-cash stock-based compensation expense totaled $137,000 (about $87,000 after tax or about $0.00 per share) for the three months and $221,000 (about $142,000 after tax or about $0.01 per share) for the six months ended December 31, 2007.

Net revenues, cost of goods sold, gross profit, gross margin, income (loss) from operations, net income (loss), and diluted earnings (loss) per share are the key indicators we use to monitor our financial condition and operating performance. We also use certain non-GAAP measures such as earnings before interest, taxes, depreciation and amortization (EBITDA) to assess business trends and performance, and to forecast and plan future operations.  The following table sets forth the key quarterly and annual GAAP financial measures we use to manage our business (in thousands, except per share data).

 

 

Fiscal Year 2009

 

Fiscal Year 2008

 

1st

 

2nd

 

1st

 

2nd

 

3rd

 

4th

 

Quarter

 

Quarter

 

Quarter

 

Quarter

 

Quarter

 

Quarter

Net revenues

$5,752

 

$5,157

 

$6,431

 

$5,685

 

$6,474

 

$5,647

Cost of goods sold

$3,132

 

$3,035

 

$3,486

 

$3,083

 

$3,409

 

$3,156

Gross profit

$2,621

 

$2,122

 

$2,945

 

$2,602

 

$3,065

 

$2,491

Gross margin

45.6%

 

41.2%

 

45.8%

 

45.8%

 

47.4%

 

44.1%

Income (loss) from operations (a)(c)

$901

 

($814)

 

($333)

 

($839)

 

($791)

 

($1,080)

Operating margin

15.7%

 

(15.8%)

 

(5.2%)

 

(14.8%)

 

(12.2%)

 

(19.1%)

Net income (loss)(b)(c)

$477

 

($517)

 

($187)

 

($485)

 

($488)

 

($664)

Diluted earnings (loss) per share

$0.04

 

($0.04)

 

($0.02)

 

($0.04)

 

($0.04)

 

($0.06)

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation included in above results:

 

 

 

 

 

 

 

 

 

 

 

(a) Pretax

$163

 

$205

 

$82

 

$137

 

$110

 

$145

(b) After-tax

$97

 

$123

 

$53

 

$87

 

$70

 

$93

(c) 1st quarter 2009 includes the benefit of the $1,500 litigation settlement (about $900 after tax).

 

 

 

RESULTS OF OPERATIONS

 

Net Revenues.   For the three months ended December 31, 2008, as compared to the same period last year, we experienced a nominally higher level of gross revenue generation and product sales volumes. However, due to an increased level of customer rebates and the revenue impact resulting from the significant devaluation of the British Pound and the Euro during the quarter (described above in the Executive Summary), our net revenues for the three months ended December 31, 2008 as compared to the same period last year, decreased by $528,000 or 9% from $5,685,000 to $5,157,000. Year-over-year, sales of color toner cartridges increased by about 14% and solid ink product sales decreased by about 15%. For this same period, we also experienced declining revenues from our INKlusive program. The decline in the volume of INKlusive revenue reflects the general trend toward lower printer prices which inherently reduces the value of the “free printer” incentive that is core to the INKlusive program.

 

Net revenues for the six months ended December 31, 2008, as compared with the same period last year, decreased by $1,207,000 or 10% from $12,116,000 to $10,909,000. This decline in net revenues was primarily driven by an increased level of customer rebates, the revenue impact resulting from the significant devaluation of the British Pound and the Euro during our fiscal second quarter, and a decrease in revenues from our INKlusive program. Also contributing to the decline was the discontinuance of sales directly to end users by our Cadapult subsidiary in the comparative year ago period ended September 30, 2007. It is also noteworthy that in the year ago fiscal quarter ended September 30, 2007 that the Company benefitted from the launch of three new products which contributed to the realization of a record net revenue quarter.

 

22

 



To Table of Contents

 

 

We ended the quarter with an order backlog of $343,000, representing a $120,000 decrease over the prior quarter ended September 30, 2008. Since we do not recognize revenues until orders are shipped, revenues associated with these unfilled orders were not recognized in the quarter ended December 31, 2008. For the comparative period, we had $235,000 of order backlog at December 31, 2007.

 

Gross Profit.   Consolidated gross profit for the three months ended December 31, 2008, compared to the same period last year, decreased by $480,000 or 18% to $2,122,000 from $2,602,000. For the three months ended December 31, 2008, our gross margins declined by about 460 basis points to 41.2% from 45.8% in the comparative year ago period. Consolidated gross profit for the six months ended December 31, 2008 compared to the same period last year, decreased by $804,000 or 14% to $4,743,000 from $5,547,000. For the six months ended December 31, 2008, our gross margins declined by about 230 basis points to 43.5% from 45.8% in the comparative year ago period.

 

These declines in the gross margins were primarily attributed to the year-over-year increase in customer rebates combined with the revenue and margin impact resulting from the significant devaluation of the British Pound and the Euro during the quarter (described above in the Executive Summary). To a lesser extent, some of the year-over-year decline was the result of our continued sales mix trend toward a greater proportion of toner-based products; the effects of which were more than offset by year-over-year reductions in our product costs, particularly inbound freight costs.

 

Our margins reflect a portfolio of products. Generally, solid ink products generate greater margins than do toner-based products. While margins within the solid ink product line are very consistent, margins within the toner-based product line vary quite significantly. As a result, our margins can vary materially, not only as a function of the solid ink to toner sales mix, but of the sales mix within the toner-based product line itself. We expect to see changes in our margins, both favorable and unfavorable, as a result of continued changes in our sales mix.

 

Research and Development.   Research and development spending for the three months ended December 31, 2008, compared to the same period last year, decreased by $121,000 or 26% to $348,000 from $469,000. For the six months ended December 31, 2008, as compared to the same period last year, decreased by $245,000 or 25% to $721,000 from $966,000.

 

The decrease in our research and development costs was the result of our cost reduction efforts. Looking forward, we expect our research and development spending to represent a similar to slightly declining proportion of our net revenues.

 

Selling, General and Administrative.   Selling, general and administrative expense, exclusive of depreciation and amortization, for the three months ended December 31, 2008, compared to the same period last year, decrease by $381,000 or 13% to $2,496,000 from $2,877,000. For the six months ended December 31, 2008, Selling, general and administrative expense, exclusive of depreciation and amortization decreased by $321,000 or 6% to $5,248,000 from $5,569,000 for the same period last year.

 

The decrease in selling, general and administrative expense was primarily driven by lower year-over-year costs of litigation and the results of our cost reduction efforts partially offset by greater year-over-year business formation and start-up costs associated with our China manufacturing operations and foreign currency translation losses (each of which are described above in the Executive Summary).

 

Selling, general and administrative expense, exclusive of depreciation and amortization, for the three and six months ended December 31, 2008 includes about $176,000 and $321,000 of non-cash stock-based compensation expense, respectively. This compares with about $124,000 and $200,000 of stock-based compensation expense in the comparative year ago three and six months ended December 31, 2007.

 

23

 



To Table of Contents

 

 

Depreciation and Amortization.   Non-manufacturing depreciation and amortization expense for the three months ended December 31, 2008 compared to the same period last year, decreased by $3,000 or 3% to $92,000 from $95,000. For the six months ended December 31, 2008, compared to the same period in 2007, non-manufacturing depreciation and amortization expense increased by $1,000 or 0.5% to $186,000 from $185,000. The nominal change in non-manufacturing depreciation and amortization expense reflects the nominal decline in the Company’s non-manufacturing fixed asset additions over the comparative periods.

 

Interest Income (Expense), net.   For the three and six months ended December 31, 2008, we had net interest expense of $98,000 and $152,000. This compares with net interest income of $1,000 and $9,000, respectively, for the prior year’s three and six months ended December 31, 2007. These changes were the result of lower year-over-year average cash balances maintained by the Company and its increased level of debt.

 

Income Taxes.   For the three and six months ended December 31, 2008, we recorded income tax benefits of $396,000 and $26,000, respectively. This compares with income tax benefits of $352,000 and $491,000, respectively, for the three and six months ended December 31, 2007. For the three and six months ended December 31, 2008, our effective tax rates were 43.4% and 40.0%, respectively. This compares with 42.5% and 42.1%, respectively, for the three and six months ended December 31, 2007. Our effective blended state and federal tax rate varies due to the magnitude of various permanent differences between reported pretax income and what is recognized as taxable income by various taxing authorities.

 

Net Income (Loss).   For the three and six months ended December 31, 2008, we lost $517,000 ($0.04 per share basic and diluted) and $39,000 ($0.00 per share basic and diluted). This compares with a net loss of $485,000 ($0.04 per share basic and diluted) and $672,000 ($0.06 per share basic and diluted), respectively, generated in the prior year for the three and six months ended December 31, 2007. Excluding the benefit of the non-recurring litigation settlement we recognized during the prior fiscal quarter, we would have generated a net loss for the six months ended December 31, 2008 of about $939,000 on a pro forma basis.

 

 

RECENT ACCOUNTING PRONOUNCEMENTS

 

See Note 1 to the Condensed Consolidated Financial Statements for a full description of recent accounting pronouncements, including the expected dates of adoption and estimated effects on our consolidated financial statements, which is incorporated herein by reference.

 

 

CRITICAL ACCOUNTING POLICIES

 

For a description of our critical accounting policies see Note 1 to the audited financial statements included in our Form 10-K for the year ended June 30, 2008 filed September 25, 2008. There were no material changes to these policies during the quarter ended December 31, 2008.

 

24

 



To Table of Contents

 

 

LIQUIDITY AND CAPITAL RESOURCES

 

During the six months ended December 31, 2008, our cash and equivalents increased by $483,000 to $719,000; $484,000 of which was held in China. $1,334,000 of this increase was provided by financing activities; primarily the proceeds from issuance of convertible debt; partially offset by $597,000 of cash used in investing activities and $193,000 used by operating activities. Cash used in investing activities included the purchase of equipment, tooling and leasehold improvements in the amount of $597,000, representing an increase of $351,000 from the comparable spend of $246,000 for the six months ended December 30, 2007. Most of this increase in capital spending was associated with our start-up operations in China.

 

We used $193,000 of cash via operating activities during the six months ended December 31, 2008 as compared with $963,000 of funds used during the six months ended December 31, 2007. The $193,000 of cash used by operating activities during the six months ended December 31, 2008 resulted from a $39,000 net loss from operations, which included $1,500,000 received on settlement of litigation, non-cash charges totaling $919,000, and $1,073,000 of cash used primarily to increase our non-cash working capital (current assets less cash and cash equivalents net of current liabilities). The most significant drivers behind the decrease in cash associated with our non-cash working capital was a $2,849,000 net reduction in our trade and accrued obligations. These uses of cash were partially offset by a $1,957,000 of cash generated from a decrease in our inventories as a result of our inventory management initiative.

 

During the six months ended December 31, 2008, our inventory levels decreased by $2,020,000 or about 22%, inclusive of changes in reserves, to $7,196,000 from $9,216,000. The decrease in raw materials and finished goods inventories was driven by our inventory management initiative. The plan integrates detailed SKU level sales forecasting, which was recently implemented, with statistical modeling that accounts for demand variability based on historic order volatility. Other elements of the plan include a reduction in minimum order quantities through our providing vendors with rolling forecasts of our production needs. Based on these quarter end inventory levels, which include raw materials, we have achieved a 46 day or 16% reduction in our days in inventory from 292 days at June 30, 2008 to 246 days at December 31, 2008.

 

We enjoyed a significant decrease in our inventories during the six months ended December 31, 2008; however we do not anticipate continued significant declines in our inventories over the coming quarters. While our inventory management program is expected to yield additional reductions in our inventories, the introduction of new products and the level of sales activity during any given period may impact our inventory levels. We have historically experienced and expect to continue to experience some volatility in our working capital demands resulting from our present toner-based product supply-chain.

 

Our INKlusive program generates operating cash flow in advance of the income statement recognition associated with printer consumables being shipped and revenues being recognized over the two year term of our typical INKlusive supply agreement. This advanced funding of the INKlusive contract consideration by a third-party leasing company results in up-front cash receipts and corresponding deferred revenue obligations. As of December 31, 2008, deferred revenue associated with the program totaled $463,000, a decrease of $205,000 from $668,000 at June 30, 2008. The operating cash flow effect of this decrease in a current liability was a corresponding decrease in cash flow generated by operations. The decline in the volume of INKlusive revenue reflects the general trend toward lower printer prices which inherently reduces the value of the “free printer” incentive that is core to the INKlusive program.

 

On September 24, 2008, we completed a $1,250,000 convertible debt financing with MicroCapital Fund, LP and MicroCapital Fund, Ltd. (“MicroCapital”). We issued three year notes, bearing interest at 10% payable quarterly and convertible into shares of our common stock at $1.65 per share. We also issued (a) five year warrants allowing MicroCapital to purchase 387,787 shares of our common stock at $1.65 per share, and (b) three year warrants allowing MicroCapital to repeat its investment up to $1,250,000 on substantially the same terms and conditions. The three year warrants may be called by us if certain criteria are met. To date, the proceeds of this financing have been used to fund the capital expenditure and working capital requirements associated with our China based manufacturing operations.

 

25

 



To Table of Contents

 

 

On February 12, 2008, the Company entered into an agreement with Sovereign Bank for a three year revolving line of credit for up to $8,000,000. As amended, the advance limit under the line of credit is the lesser of: (a) $8,000,000; or (b) up to 80% of eligible accounts receivable plus up to the lesser of: (i) $3,000,000; or (ii) 50% of eligible inventory; or (iii) 60% of the maximum amount available to be advanced under the line. The line of credit is collateralized by a first priority security interest in substantially all of our U.S. based assets. On May 14, 2008, we entered into an amendment to the loan agreement that amended the range of interest rates applicable to our borrowings. As amended, under a prime rate option, the interest rate can vary from the bank’s prime rate to its prime rate plus 1%, and, under a LIBOR rate option, the interest rate can vary from LIBOR plus 225 basis points to LIBOR plus 275 basis points. Both the term note and the line of credit bear interest at the bank’s Prime Rate plus 1% (4.25% at December 31, 2008) and require payments of interest only through the facility’s three year term. No principal payments are required under the term note or line of credit until the facility matures on February 11, 2011; subject to renewal or extension by the parties.

 

The revolving loan may be converted into one or more term notes upon mutual agreement of the parties. On February 12, 2008, we entered into a non-amortizing term note with the bank in the amount of $1,500,000, due February 12, 2011. At December 31, 2008, this note had a principal balance of $1,500,000. As of December 31, 2008, we had an outstanding balance of $1,378,683 under the revolving line and approximately $261,000 of undrawn availability under our credit line. The applicable interest rate on the revolving and term loans extended under the agreement varies based upon certain financial criteria.

 

We have been subject to financial covenants in our current and former credit facilities. Our current financial covenants include monitoring a ratio of debt to tangible net worth and a fixed charge coverage ratio, as defined in the loan agreements. At December 31, 2008, we were in compliance with all of our financial covenants. At June 30, 2008, we were not in compliance with our financial covenants, which were waived by the bank via an amendment dated September 22, 2008. As a result of a cross default and collateralization provision associated with our former debt facility, we agreed to refinance certain operating leases held by an affiliate of our former bank. Under terms of a separate waiver and amendment with this leasing affiliate, we received an extension of time to refinance or payoff the lease obligation until March 31, 2009. At December 31, 2008, the remaining obligation under the agreement was $328,488. Under the terms of this amendment, we agreed to make six lease payments of $50,000 per month between October 2008 and March 2009 and refinance or otherwise payoff any remaining balance on or before March 31, 2009. Upon full satisfaction of this obligation we will obtain title to the leased equipment. Based on the amended lease terms, which include an agreed upon interest charge of prime plus 2.5% per annum, the remaining balance at March 31, 2009 will be approximately $245,000. This obligation may be refinanced or otherwise prepaid at anytime without penalty.

 

Over the next twelve months, our operations may require additional funds and may seek to raise such additional funds through public or private sales of debt or equity securities, or securities convertible or exchangeable into such securities, strategic relationships, bank debt, lease financing arrangements, or other available means. We cannot provide assurance that additional funding, if sought, will be available or, if available, will be on acceptable terms to meet our business needs. If additional funds are raised through the issuance of equity securities, stockholders may experience dilution, or such equity securities may have rights, preferences, or privileges senior to those of the holders of our common stock. If additional funds are raised through debt financing, the debt financing may involve significant cash payment obligations and financial or operational covenants that may restrict our ability to operate our business. An inability to fund our operations or fulfill outstanding obligations could have a material adverse effect on our business, financial condition and results of operations.

 

 

SEASONALITY

 

Historically, we have not experienced any significant seasonality in our business. As we continue to grow our international business relative to our North American business and as our distribution channel customer mix changes, we may experience a more notable level of seasonality, especially during the summer months and other periods such as calendar year end.

 

26

 



To Table of Contents

 

 

MARKET RISK

 

We are exposed to various market risks, including changes in foreign currency exchange rates and commodity price inflation. Market risk is the potential loss arising from adverse changes in market rates and prices, such as foreign currency exchange, commodity price inflation and interest rates. We do not hedge our foreign currency exposures as the net impact of these exposures has historically been insignificant. We had no forward foreign exchange contracts outstanding as of December 31, 2008. In the future we may hedge these exposures based on our assessment of their significance.

 

Foreign Currency Exchange Risk

 

A significant portion of our business is conducted in countries other than the U.S. We are primarily exposed to changes in exchange rates for the Euro, the British Pound, the Japanese yen, and the Chinese yuan. At December 31, 2008, about 58% of our receivables were invoiced and collected in U.S. dollars. Beginning in our fiscal second quarter ended December 31, 2007, we were exposed to currency exchange risk from Euro and British pound-denominated sales. For these transactions we expect to be a net receiver of the foreign currency and therefore benefit from a weaker U.S. dollar and are adversely affected by a stronger U.S. dollar.

 

Today, a significant portion of our toner-based products are purchased in U.S. dollars from Asian vendors and contract manufacturers. Although such transactions are denominated in U.S. dollars, over time, we are adversely affected by a weaker U.S. dollar, in the form of price increases, and, conversely, benefit from a stronger U.S. dollar. A majority of operating expenses associated with the start-up of our Asian manufacturing operations are also settled in non-U.S. dollar denominated currencies, in particular the Chinese Yuan. In these transactions, we benefit from a stronger U.S. dollar and are adversely affected by a weaker U.S. dollar. Accordingly, changes in exchange rates, and in particular a weakening of the U.S. dollar, may adversely affect our consolidated operating expenses and operating margins which are expressed in U.S. dollars.

 

See discussion in the Executive Summary regarding the impact during the current reporting periods of changes in foreign exchange rates.

 

Commodity Price Inflation Risk

 

Over the last twelve months, we have experienced increases in raw material costs and the costs of shipping and freight to deliver those materials and finished products to our facility and, where paid for by us, shipments to customers. While we have historically offset a significant portion of this inflation in operating costs through increased productivity and improved yield, recent increases have impacted profit margins. We are pursuing efforts to improve our procurement of raw materials. We can provide no assurance that our efforts to mitigate increases in raw materials and shipping and freight costs will be successful.

 

Interest Rate Risk

 

At December 31, 2008, the Company had about $2,879,000 of debt outstanding under its line of credit and term notes. Interest expense under this line of credit is variable, based on its lender’s prime rate. Accordingly, the Company is subject to interest rate risk in the form of greater interest expense in the event of rising interest rates. We estimate that a 10% increase in interest rates, based on the Company’s present level of borrowings, would result in the Company incurring about $12,000 pretax ($7,200 after tax) of greater interest expense.

 

27

 



To Table of Contents

 

 

ITEM 3.   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Reference is made to the information set forth under the caption “Market Risk” included in Item 2 of Part I of this report, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Also refer to the last paragraph of “Liquidity and Capital Resources” contained in this report for additional discussion of issues regarding liquidity.

 

 

ITEM 4.   CONTROLS AND PROCEDURES

 

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report.  Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure controls and procedures are effective. In addition, no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) occurred during the quarter ended December 31, 2008 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

28

 



To Table of Contents

 

 

PART II.  OTHER INFORMATION

 

ITEM 1.   LEGAL PROCEEDINGS

 

The information set forth above under Note 9 contained in the “Notes to Condensed Consolidated Financial Statements” is incorporated herein by reference.

 

 

ITEM 1A.   RISK FACTORS

 

A description of factors that could materially affect our business, financial condition or operating results is included in Item 1A “Risk Factors” of our Form 10-K for the year ended June 30, 2008, filed September 25, 2008 and is incorporated herein by reference.

 

 

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Not applicable.

 

 

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

 

Not applicable.

 

 

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

We held an annual meeting of stockholders on December 18, 2008, at which our stockholders voted on the following items:

 

1.

the election of seven directors to serve until the next annual meeting and until their successors have been duly elected and qualified;

2.

approval of the Company’s 2009 Stock Incentive Plan; and

3.

the ratification of the selection of Amper, Politziner & Mattia, P.C. as our independent registered public accounting firm for the fiscal year ending June 30, 2009.

 

The nominees for directors were elected based upon the following votes:

 

 

 

For

 

Votes Withheld

1.

Election of directors

 

 

 

 

Michael W. Levin

10,166,252

 

337,195

 

Paul C. Baker

10,166,252

 

337,195

 

Edwin Ruzinsky

10,166,252

 

337,195

 

Henry Royer

10,166,252

 

337,195

 

Dennis Ridgeway

10,166,252

 

337,195

 

Willem van Rijn

10,116,252

 

387,195

 

Frank J. Tanki

10,116,252

 

387,195

 

The voting results on the other proposals were as follow:

 

 

 

For

 

Against

 

Abstentions

 

Non-Votes

2.

Approval of the 2009 Stock Incentive Plan

2,626,405

 

454,074

 

81,194

 

7,341,774

3.

Ratification of selection of independent registered public accounting firm

10,407,713

 

15,000

 

80,734

 

 

 

29

 



To Table of Contents

 

 

ITEM 5.  OTHER INFORMATION

 

Not applicable.

 

 

ITEM 6.   EXHIBITS

 

The following exhibits are filed with this report:

 

Exhibit No.

 

Description

10.1+

 

2009 Stock Incentive Plan (incorporated by reference to Exhibit 4.9 of Form S-8, filed on February 5, 2009)

10.2*+

 

2006 Stock Incentive Plan, as Amended and Restated

31.1*

 

Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a)

31.2*

 

Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a)

32.1*

 

Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350

32.2*

 

Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350

 

* Filed herewith

+ Represents executive compensation plan or agreement

 

30

 



To Table of Contents

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Dated: February 12, 2009

 

 

 

Dated: February 12, 2009

MEDIA SCIENCES INTERNATIONAL, INC.

 

By:         /s/ Michael W. Levin

Michael W. Levin

Chief Executive Officer and President

 

By:         /s/ Kevan D. Bloomgren

Kevan D. Bloomgren

Chief Financial Officer

 

 

 

31